Patriot Financial Group Insurance Agency, LLC Crispr Therapeutics Ag Transaction History
Patriot Financial Group Insurance Agency, LLC
- $704 Million
- Q4 2024
A detailed history of Patriot Financial Group Insurance Agency, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Patriot Financial Group Insurance Agency, LLC holds 22,658 shares of CRSP stock, worth $988,341. This represents 0.13% of its overall portfolio holdings.
Number of Shares
22,658
Previous 29,586
23.42%
Holding current value
$988,341
Previous $1.39 Million
35.9%
% of portfolio
0.13%
Previous 0.19%
Shares
28 transactions
Others Institutions Holding CRSP
# of Institutions
486Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$391 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$381 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$166 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$121 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$120 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.4B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....